Background Higher levels of serum phosphorus and the calcium-phosphorus product are
associated with increased mortality from cardiovascular disease (CVD) in patients with …

Background Vascular calcification is the most prominent underlying pathological finding in
patients with uraemia, and is a predictor of mortality in this population. Fetuin-A (α 2 …

Background—Higher levels of serum phosphate are associated with adverse cardiovascular
outcomes, especially in the setting of overt hyperphosphatemia. Given the biological …

Objective: To develop evidence-based recommendations for safe, effective, and appropriate
treatment of secondary (SHPT) and tertiary (THPT) renal hyperparathyroidism. Background …

Although for most children the process of atherosclerosis is subclinical, dramatically
accelerated atherosclerosis occurs in some pediatric disease states, with clinical coronary …

Background Phosphate binders are used to reduce positive phosphate balance and to lower
serum phosphate levels for people with chronic kidney disease (CKD) with the aim to …

To make an evidence-based evaluation of the relationship between kidney failure and
cardiovascular risk, we reviewed the literature obtained from a PubMed search using pre …

Background It has been suggested that a higher calcium intake might favourably modify
cardiovascular risk factors. However, findings of an ultimately decreased risk of …

Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and
Practice Patterns Study. Background Altered mineral metabolism contributes to bone …

Background Elevated calcium and phosphorus levels after therapy with injectable vitamin D
for secondary hyperparathyroidism may accelerate vascular disease and hasten death in …